Our CommitmentWe are committed to leveraging our expertise in immunology to fulfill our purpose of developing innovative new medicines that improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer.
Learn More
Our ScienceCorbus’ pipeline encompasses two different approaches to immunology: small molecules that activate or inhibit the body’s endocannabinoid system and monoclonal antibodies that target integrins to inhibit activation of TGFβ.
Learn MoreWe are a unique team of individuals who are high-achieving, innovative, creative, and above all else, passionate about what we do.
